International Journal of Endocrinology and Metabolism

Published by: Kowsar

Relationship Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran

Marzieh Bakhshayeshkaram 1 , Jamshid Roozbeh 2 , Seyed Taghi Heidari 1 , Behnam Honarvar 1 , Mohammad Hossein Dabbaghmanesh 3 and Kamran B. Lankarani 1 , *
Authors Information
1 Shiraz Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran
2 Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Shiraz Endocrinology and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • International Journal of Endocrinology and Metabolism: 17 (2); e81822
  • Published Online: February 27, 2019
  • Article Type: Research Article
  • Received: July 7, 2018
  • Revised: February 10, 2019
  • Accepted: February 17, 2019
  • DOI: 10.5812/ijem.81822

To Cite: Bakhshayeshkaram M, Roozbeh J, Heidari S T, Honarvar B, Dabbaghmanesh M H, et al. Relationship Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran, Int J Endocrinol Metab. Online ahead of Print ; 17(2):e81822. doi: 10.5812/ijem.81822.

Abstract
Copyright © 2019, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Prasad GV. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol. 2014;3(4):210-9. doi: 10.5527/wjn.v3.i4.210. [PubMed: 25374814]. [PubMed Central: PMC4220353].
  • 2. Ardhanari S, Alpert MA, Aggarwal K. Cardiovascular disease in chronic kidney disease: Risk factors, pathogenesis, and prevention. Adv Perit Dial. 2014;30:40-53. [PubMed: 25338421].
  • 3. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: A systematic review. BMC Public Health. 2017;17(1):101. doi: 10.1186/s12889-017-4041-1. [PubMed: 28109251]. [PubMed Central: PMC5251315].
  • 4. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6(10):2364-73. doi: 10.2215/CJN.02180311. [PubMed: 21852664]. [PubMed Central: PMC3186450].
  • 5. Nashar K, Egan BM. Relationship between chronic kidney disease and metabolic syndrome: Current perspectives. Diabetes Metab Syndr Obes. 2014;7:421-35. doi: 10.2147/DMSO.S45183. [PubMed: 25258547]. [PubMed Central: PMC4173754].
  • 6. Sarathy H, Henriquez G, Abramowitz MK, Kramer H, Rosas SE, Johns T, et al. Abdominal obesity, race and chronic kidney disease in young adults: Results from NHANES 1999-2010. PLoS One. 2016;11(5). e0153588. doi: 10.1371/journal.pone.0153588. [PubMed: 27224643]. [PubMed Central: PMC4880194].
  • 7. Maleki A, Montazeri M, Rashidi N, Montazeri M, Yousefi-Abdolmaleki E. Metabolic syndrome and its components associated with chronic kidney disease. J Res Med Sci. 2015;20(5):465-9. doi: 10.4103/1735-1995.163969. [PubMed: 26487875]. [PubMed Central: PMC4590201].
  • 8. Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol. 2009;5(9):520-8. doi: 10.1038/nrneph.2009.114. [PubMed: 19636332].
  • 9. National Center for Health Statistics. National health and nutrition examination survey. Physician examination procedures manual. 2013.
  • 10. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006. [PubMed: 19414839]. [PubMed Central: PMC2763564].
  • 11. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet. 2005;366(9491):1059-62. doi: 10.1016/s0140-6736(05)67402-8. [PubMed: 16182882].
  • 12. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003;61(1):29-37. doi: 10.1016/s0168-8227(03)00066-4. [PubMed: 12849921].
  • 13. Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the united states, national health and nutrition examination survey, 1988-2012. Prev Chronic Dis. 2017;14. E24. doi: 10.5888/pcd14.160287. [PubMed: 28301314]. [PubMed Central: PMC5364735].
  • 14. Mankowski RT, Aubertin-Leheudre M, Beavers DP, Botoseneanu A, Buford TW, Church T, et al. Sedentary time is associated with the metabolic syndrome in older adults with mobility limitations--The LIFE Study. Exp Gerontol. 2015;70:32-6. doi: 10.1016/j.exger.2015.06.018. [PubMed: 26130060]. [PubMed Central: PMC4600654].
  • 15. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-4. doi: 10.1001/jama.2015.4260. [PubMed: 25988468].
  • 16. Krishnadath IS, Toelsie JR, Hofman A, Jaddoe VW. Ethnic disparities in the prevalence of metabolic syndrome and its risk factors in the Suriname Health Study: A cross-sectional population study. BMJ Open. 2016;6(12). e013183. doi: 10.1136/bmjopen-2016-013183. [PubMed: 27927663]. [PubMed Central: PMC5168639].
  • 17. Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JC, et al. Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabetes Obes Metab. 2004;6(5):353-62. doi: 10.1111/j.1462-8902.2004.00354.x. [PubMed: 15287928].
  • 18. Chen J, Kong X, Jia X, Li W, Wang Z, Cui M, et al. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population. Clin Chim Acta. 2017;470:103-8. doi: 10.1016/j.cca.2017.05.012. [PubMed: 28501388].
  • 19. Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, et al. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: The Jackson Heart Study. PLoS One. 2014;9(7). e101610. doi: 10.1371/journal.pone.0101610. [PubMed: 24991817]. [PubMed Central: PMC4081650].
  • 20. Poudel B, Gyawali P, Yadav BK, Nepal AK, Mahato RV, Jha B, et al. Prevalence of metabolic syndrome in chronic kidney disease: A hospital based cross-sectional study. J Nepal Health Res Counc. 2013;11(24):208-11. [PubMed: 24362613].
  • 21. Hu W, Wu XJ, Ni YJ, Hao HR, Yu WN, Zhou HW. Metabolic syndrome is independently associated with a mildly reduced estimated glomerular filtration rate: A cross-sectional study. BMC Nephrol. 2017;18(1):192. doi: 10.1186/s12882-017-0597-3. [PubMed: 28610620]. [PubMed Central: PMC5470228].
  • 22. Madero M, Katz R, Murphy R, Newman A, Patel K, Ix J, et al. Comparison between different measures of body fat with kidney function decline and incident CKD. Clin J Am Soc Nephrol. 2017;12(6):893-903. doi: 10.2215/CJN.07010716. [PubMed: 28522656]. [PubMed Central: PMC5460706].
  • 23. Camara NO, Iseki K, Kramer H, Liu ZH, Sharma K. Kidney disease and obesity: Epidemiology, mechanisms and treatment. Nat Rev Nephrol. 2017;13(3):181-90. doi: 10.1038/nrneph.2016.191. [PubMed: 28090083].
  • 24. Medeiros T, do Rosario NF, Gama NA, Merida LAD, Storch AS, Ferraz L, et al. Metabolic syndrome components and estimated glomerular filtration rate based on creatinine and/or cystatin C in young adults: A gender issue? Diabetes Metab Syndr. 2017;11 Suppl 1:S351-7. doi: 10.1016/j.dsx.2017.03.015. [PubMed: 28284908].
  • 25. Landecho MF, Colina I, Huerta A, Fortuno A, Zalba G, Beloqui O. [Connection between the early phases of kidney disease and the metabolic syndrome]. Rev Esp Cardiol. 2011;64(5):373-8. Spanish. doi: 10.1016/j.recesp.2010.11.011. [PubMed: 21481511].
  • 26. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol. 2006;17(8):2106-11. doi: 10.1681/ASN.2005121288. [PubMed: 16825333].
  • 27. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291(7):844-50. doi: 10.1001/jama.291.7.844. [PubMed: 14970063].
  • 28. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426-8. [PubMed: 20804311].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments